Esperion Therapeutics
ESPR
ESPR
131 hedge funds and large institutions have $218M invested in Esperion Therapeutics in 2023 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 35
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8.14% less ownership
Funds ownership: 72.23% → 64.1% (-8.1%)
Holders
131
Holding in Top 10
2
Calls
$10.3M
Puts
$2.4M
Top Buyers
| 1 | +$9.57M | |
| 2 | +$3.63M | |
| 3 | +$3.63M | |
| 4 |
WCM
Whitefort Capital Management
New York
|
+$2.65M |
| 5 |
Two Sigma Investments
New York
|
+$2.62M |
Top Sellers
| 1 | -$9.25M | |
| 2 | -$7.88M | |
| 3 | -$7.01M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$4.19M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$3.61M |